D. I. C. SCOPES

2.4k total citations
87 papers, 1.9k citations indexed

About

D. I. C. SCOPES is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, D. I. C. SCOPES has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Organic Chemistry, 40 papers in Molecular Biology and 15 papers in Physiology. Recurrent topics in D. I. C. SCOPES's work include Synthesis and Biological Evaluation (14 papers), Alzheimer's disease research and treatments (12 papers) and Receptor Mechanisms and Signaling (10 papers). D. I. C. SCOPES is often cited by papers focused on Synthesis and Biological Evaluation (14 papers), Alzheimer's disease research and treatments (12 papers) and Receptor Mechanisms and Signaling (10 papers). D. I. C. SCOPES collaborates with scholars based in United Kingdom, United States and Bangladesh. D. I. C. SCOPES's co-authors include Ann G. Hayes, Nelson J. Leonard, Duncan B. Judd, Alan Naylor, Hozefa Amijee, M.B. Tyers, Helen E. Connor, M. Skingle, W. Feniuk and Ian W. Davies and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

D. I. C. SCOPES

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. I. C. SCOPES United Kingdom	23	995	772	451	319	164	87	1.9k
Marlon Cowart United States	34	1.7k 1.7×	673 0.9×	365 0.8×	394 1.2×	151 0.9×	71	3.1k
Magid Abou‐Gharbia United States	28	914 0.9×	703 0.9×	319 0.7×	160 0.5×	301 1.8×	112	2.3k
Jean‐Luc Fauchère France	26	1.6k 1.6×	341 0.4×	950 2.1×	350 1.1×	67 0.4×	85	3.0k
Sabrina Taliani Italy	36	1.8k 1.8×	1.2k 1.6×	490 1.1×	286 0.9×	268 1.6×	145	3.6k
Philip Jones United States	33	2.7k 2.8×	522 0.7×	585 1.3×	176 0.6×	287 1.8×	92	3.6k
Henk Timmerman Netherlands	36	2.4k 2.5×	517 0.7×	799 1.8×	521 1.6×	171 1.0×	112	4.2k
Brian Lockhart France	24	956 1.0×	352 0.5×	450 1.0×	518 1.6×	380 2.3×	51	2.0k
David S. Duch United States	25	1.2k 1.2×	548 0.7×	140 0.3×	342 1.1×	112 0.7×	62	2.6k
Sander G. Mills United States	30	1.2k 1.2×	1.2k 1.5×	381 0.8×	125 0.4×	123 0.8×	77	2.6k
John Saunders United States	28	1.3k 1.3×	1.3k 1.7×	410 0.9×	124 0.4×	145 0.9×	139	3.1k

Countries citing papers authored by D. I. C. SCOPES

Since Specialization

Citations

This map shows the geographic impact of D. I. C. SCOPES's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. I. C. SCOPES with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. I. C. SCOPES more than expected).

Fields of papers citing papers by D. I. C. SCOPES

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. I. C. SCOPES. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. I. C. SCOPES. The network helps show where D. I. C. SCOPES may publish in the future.

Co-authorship network of co-authors of D. I. C. SCOPES

This figure shows the co-authorship network connecting the top 25 collaborators of D. I. C. SCOPES. A scholar is included among the top collaborators of D. I. C. SCOPES based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. I. C. SCOPES. D. I. C. SCOPES is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brunner, Daniela, Stefanie Flunkert, Joerg Neddens, et al.. (2017). SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer’s disease. Neuroscience Letters. 660. 96–102. 3 indexed citations

Lo, Adrian C., Ina Tesseur, D. I. C. SCOPES, et al.. (2013). Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500. Neuropharmacology. 75. 458–466. 11 indexed citations

O‘Hare, Eugene, D. I. C. SCOPES, Eun‐Mee Kim, et al.. (2013). Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease. The International Journal of Neuropsychopharmacology. 17(1). 117–126. 10 indexed citations

O‘Hare, Eugene, D. I. C. SCOPES, Eun‐Mee Kim, et al.. (2012). Orally bioavailable small molecule drug protects memory in Alzheimer's disease models. Neurobiology of Aging. 34(4). 1116–1125. 14 indexed citations

O‘Hare, Eugene, D. I. C. SCOPES, J. Mark Treherne, et al.. (2011). Novel Anti-Inflammatory Compound SEN1176 Alleviates Behavioral Deficits Induced Following Bilateral Intrahippocampal Injection of Aggregated Amyloid-β1-42. Journal of Alzheimer s Disease. 25(2). 219–229. 21 indexed citations

O‘Hare, Eugene, et al.. (2010). RS-0406 Arrests Amyloid-β Oligomer-Induced Behavioural Deterioration In Vivo. Behavioural Brain Research. 210(1). 32–37. 16 indexed citations

Courtney, Stephen M., Richard T. Buck, David J. Phillips, et al.. (2005). Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorganic & Medicinal Chemistry Letters. 15(9). 2295–2299. 59 indexed citations

Courtney, Stephen M., Richard T. Buck, David W. Porter, et al.. (2004). 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3269–3273. 42 indexed citations

Orchard, Michael G., Andrew N. Carr, David W. Porter, et al.. (2004). Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). Bioorganic & Medicinal Chemistry Letters. 14(15). 3975–3978. 107 indexed citations

10.

Chapman, Timothy M., Baohua Gu, Timothy M. Block, et al.. (2004). Glyco- and Peptidomimetics from Three-Component Joullié−Ugi Coupling Show Selective Antiviral Activity. Journal of the American Chemical Society. 127(2). 506–507. 71 indexed citations

11.

Naylor, Alan, Duncan B. Judd, D. I. C. SCOPES, Ann G. Hayes, & P.J. Birch. (1994). 4-[(Alkylamino)methyl]furo[3,2-c]pyridines: A New Series of Selective .kappa.-Receptor Agonists. Journal of Medicinal Chemistry. 37(14). 2138–2144. 29 indexed citations

12.

Judd, Duncan B., Michael D. Dowle, David Middlemiss, et al.. (1994). Bromobenzofuran-Based Non-peptide Antagonists of Angiotensin II: GR138950, a Potent Antihypertensive Agent with High Oral Bioavailability. Journal of Medicinal Chemistry. 37(19). 3108–3120. 33 indexed citations

13.

CLITHEROW, J. W., D. I. C. SCOPES, M. Skingle, et al.. (1994). Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D Antagonists. Journal of Medicinal Chemistry. 37(15). 2253–2257. 89 indexed citations

14.

Naylor, Alan, et al.. (1993). A potent new class of .kappa.-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines. Journal of Medicinal Chemistry. 36(15). 2075–2083. 83 indexed citations

15.

SCOPES, D. I. C., D. Neil Hayes, David Belton, et al.. (1992). New .kappa.-receptor agonists based upon a 2-[(alkylamino)methyl]piperidine nucleus. Journal of Medicinal Chemistry. 35(3). 490–501. 18 indexed citations

16.

Robertson, Mark J., Jen Barnes, G.M. Drew, et al.. (1992). Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT₁ receptor antagonist. British Journal of Pharmacology. 107(4). 1173–1180. 66 indexed citations

17.

Rogers, H. L., P.J. Birch, Susan M. Harrison, et al.. (1992). GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity. British Journal of Pharmacology. 106(4). 783–789. 34 indexed citations

18.

Judd, Duncan B., Dearg S. Brown, Andrew B. McElroy, et al.. (1992). Synthesis, antinociceptive activity and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenols. Journal of Medicinal Chemistry. 35(1). 48–56. 5 indexed citations

19.

Hayes, Ann G., P.J. Birch, Neil J. Hayward, et al.. (1990). A series of novel, highly potent and selective agonists for the κ‐opioid receptor. British Journal of Pharmacology. 101(4). 944–948. 30 indexed citations

20.

Knutsen, Lars J. S., Brian D. Judkins, Roger F. Newton, & D. I. C. SCOPES. (1982). A novel elimination reaction of 3,4,6-tri--benzoyl-2,5-anhydro-D-allonic acid: ribosyl → 2′-deoxyribosyl conversion. Tetrahedron Letters. 23(9). 1013–1014. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact